Valerie Jansen
Patrimonio netto: - $ in data 31/08/2026
Patrimonio netto: - $ in data 31/08/2026
Valerie Malyvanh Jansen is currently an Independent Director at OnKure Therapeutics, Inc. since 2024.
Former roles include Chief Medical Officer at Elevation Oncology, Inc. from 2021 to 2025 and Executive Medical Director at Mersana Therapeutics, Inc. from 2020 to 2021.
Education includes undergraduate studies at Maryville College, and doctorate degrees from The University of Tennessee Health Science Center and Pritzker School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
-.--% | 07/08/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|
| Società | Posizione | Fine |
|---|---|---|
| ELEN ONCO | Direttore Tecnico/Scientifico/R&S | 31/03/2025 |
| MERSANA THERAPEUTICS | Direttore Tecnico/Scientifico/R&S | 01/04/2021 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Maryville College
Maryville College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Tennessee Health Science Center
The University of Tennessee Health Science Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pritzker School of Medicine
Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elevation Oncology, Inc.
Elevation Oncology, Inc. BiotechnologyHealth Technology Develops elevating precision medicines for cancer treatment | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale